PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1455662
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1455662
3D bio-printed human tissue Market size was valued at USD 2,800.54 Million in 2023, expanding at a CAGR of 9.85% from 2024 to 2032.
3D bio-printed human tissue represents a groundbreaking technology that involves the layer-by-layer construction of living tissue structures utilizing biocompatible materials and living cells. This state-of-the-art method enables precise cell and biomaterial deposition to emulate the intricate architecture and functionality of native tissues and organs. Through the utilization of advanced bioprinting techniques, researchers and scientists can fabricate intricate tissue frameworks incorporating vascular networks, cellular organization, and tissue-specific functionalities.
3D bio-printed human tissue Market- Market Dynamics
Technological advancements leading to expanded applications and the growing demand for personalized 3D bioprinted tissue engineering and organ replacement to propel market demand
Key drivers of 3D bio-printed human tissue market growth include technological advancements leading to expanded applications and the growing demand for personalized 3D bioprinted tissue engineering and organ replacement. A March 2022 article published by ScienceDirect highlights 3D bioprinting as a promising approach for engineering complex tissues, offering meticulous control over cellular components to mimic the intricate hierarchy and complexity of native human tissues. Recent progress in innovative forms of living building blocks and enabling bioprinting techniques has significantly broadened the capacity to engineer more complex and functional tissues, further extending their applications in engineering disease models, microphysiological systems, and biobots. Additionally, as reported by a March 2021 article from Science Daily, researchers at Lund University in Sweden have developed a new bio-ink facilitating the 3D bioprinting of small human-sized airways using patient cells. These 3D-printed constructs are biocompatible and support the growth of new blood vessels into the transplanted material. Consequently, such advancements are anticipated to fuel the demand for 3D bioprinted human tissues, driving market growth.
3D bio-printed human tissue Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 9.85% over the forecast period (2024-2032)
Based on Biomaterial type segmentation, Natural was predicted to show maximum market share in the year 2023
Based on Application segmentation, Drug Testing and Development was the leading type in 2023
On the basis of region, North America was the leading revenue generator in 2023
The Global 3D bio-printed human tissue Market is segmented on the basis of Biomaterial type, Application, and Region.
The market is divided into two categories based on Biomaterial type: natural and synthetic. Natural segment dominate the biomaterials landscape, surpassing synthetic polymers in 2023. Materials such as collagen and gelatin exhibit exceptional biocompatibility and bioactivity, closely resembling the extracellular matrix of human tissues. They support cell adhesion, proliferation, and differentiation, making them highly desirable for bio-printing applications. Moreover, natural polymers offer advantages in terms of immunogenicity and biodegradability, minimizing adverse reactions and enabling seamless integration with host tissue. Consequently, natural polymers remain the preferred choice for bio-printing processes, driving advancements in regenerative medicine, tissue engineering, and organ transplantation.
The market is divided into five categories based on Application: Tissue Engineering, Cosmetic Surgery, Drug Testing and Development, Food Testing and Other Applications. Drug Testing and Development are expected to hold a significant market share. The utilization of 3D bioprinted human tissue in drug testing plays a crucial role. These tissues are of paramount importance for drug testing and clinical trial applications, with the potential to significantly reduce the necessity for animal trials, thereby offering ethical benefits and cost-effectiveness. Traditionally, new drug development involved clinical trials on animals with artificially-induced affected tissues. However, with the introduction of 3D bioprinted human tissue, drug inventers can address problems related with human medical trials by identifying them within a short period, as these tissues closely resemble human physiology. This reduces losses incurred during late-stage failures. For instance, according to a September 2021 article published by the National Library of Medicine, 3D printing enhances existing drug screening platforms by precisely depositing biomaterials comprising patient-derived cells and reproducing the natural environment of the diseased human body.
3D bio-printed human tissue Market- Geographical Insights
Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.
In the market, companies specializing in 3D bio-printed human tissue are pioneers in regenerative medicine and tissue engineering. They invest in research and development to refine bioprinting processes, optimize biomaterial formulations, and enhance cell viability and functionality within printed constructs. Additionally, these companies collaborate with academic institutions, healthcare providers, and pharmaceutical companies to explore potential applications in drug discovery, disease modeling, and personalized medicine. Furthermore, marketing endeavors aim to raise awareness of the capabilities of 3D bio-printed human tissue and its potential to revolutionize healthcare by providing innovative solutions for tissue repair, regeneration, and replacement. Furthermore, increasing product innovation and collaborations funded by key market players and government agencies will support market growth over the forecast period.
In November 2022, Northrop Grumman's 18th Commercial Resupply Services (NG-18) mission launched an upgraded version of Redwire Space's BioFabrication Facility (BFF), a 3D bioprinter capable of printing human tissue. Sponsored by the ISS National Laboratory, this project paved the way for in-space bioprinting tissues to aid patients back on Earth.
In November 2022, Avay Biosciences introduced an indigenous 3D printer, Mito Plus, capable of printing human tissues, adding to the market's growth through product innovations.
GLOBAL 3D BIO-PRINTED HUMAN TISSUE MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
Shinano Kenshi
MinebeaMitsumi
Nidec Servo
Moons'
Sanyo Denki
Oriental Motor
Tamagawa Seiki, and Fulling Motor
Nippon Pulse Motor
Nanotec
AMETEK
Sonceboz
Phytron
MICRO STEP GmbH
STOGRA.
Others